Close X
Tuesday, December 3, 2024
ADVT 
International

Nagara Foundation halts gurdwara renovation work in Pakistan

Darpan News Desk IANS, 20 Jan, 2022 12:05 PM
  • Nagara Foundation halts gurdwara renovation work in Pakistan

New Delhi, Jan 20 (IANS) US-based Ranjit Nagara Foundation, which was overseeing the 'karsewa' (renovation/construction) of Gurdwara Chowa Sahib in Jhelum, Pakistan and other local gurdwaras, has notified that they has stopped the construction activities due to non-compliance of ETPB/PSGPC in providing them bills and expenditure details of the works carried out till date.

Satpreet Singh, Director of Ranjit Nagara Foundation, revealed that as per US rules, their foundation has to provide documentation of their expenditure to Internal Revenue Service, Department of Justice, annually which is further updated on the department's site for public or on before May 15, but the Evacuee Trust Property Board (ETPB) office has not provided the requisite documents till date. Thus, the NGO has to put its activities on hold.

Misappropriation of gurdwara funds by ETPB/PSGPC (Pakistan Sikh Gurdwara Parbandhak Committee) officials had been reported in the past as well.

The Nagara Foundation is largely funded by the Sikh diaspora with resources being further transferred to Pakistan

MORE International ARTICLES

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown